BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Transl Oncol 2021;14:101029. [PMID: 33550204 DOI: 10.1016/j.tranon.2021.101029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mucke HAM. Drug Repurposing Patent Applications January-March 2021. Assay Drug Dev Technol 2021;19:300-5. [PMID: 33945331 DOI: 10.1089/adt.2021.051] [Reference Citation Analysis]
2 Czerwiński M, Bednarska-Czerwińska A, Zmarzły N, Boroń D, Oplawski M, Grabarek BO. Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer. J Clin Med 2021;10:4872. [PMID: 34768392 DOI: 10.3390/jcm10214872] [Reference Citation Analysis]
3 Kadioglu O, Elbadawi M, Fleischer E, Efferth T. Identification of Novel Anthracycline Resistance Genes and Their Inhibitors. Pharmaceuticals (Basel) 2021;14:1051. [PMID: 34681275 DOI: 10.3390/ph14101051] [Reference Citation Analysis]
4 Shen YC, Hsu HC, Lin TM, Chang YS, Hu LF, Chen LF, Lin SH, Kuo PI, Chen WS, Lin YC, Chen JH, Liang YC, Chang CC. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection. J Clin Oncol 2022;:JCO2101802. [PMID: 35044851 DOI: 10.1200/JCO.21.01802] [Reference Citation Analysis]